MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$172,234K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Proceeds from sales and maturiti...
Proceeds from issuance of common...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Net accretion of discounts on in...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Stock-based compensation
14,531
Net loss
-182,779
Other
0
Noncash operating lease expense
316
Prepaid expenses and other assets
4,202
Other noncurrent liabilities
877
Operating lease liabilities
-354
Accrued expenses
4,150
Accounts payable
-752
Change in fair value of warrant liability
-516
Depreciation
18
Amortization of debt discount and accretion of deferred debt costs
773
Net accretion of discounts on investments in marketable securities
4,224
Net cash used in operating activities
-172,162
Proceeds from sales and maturities of marketable securities
212,131
Purchases of property and equipment
72
Purchases of marketable securities
326,514
Net cash used in investing activities
-114,455
Proceeds from issuance of common stock upon exercise of common stock warrants
0
Proceeds from issuance of common stock under employee stock purchase plan
263
Proceeds from issuance of common stock upon exercise of stock options
59
Payments for taxes related to net share settlement upon vesting of restricted stock units
1,598
Payments of deferred offering costs
0
Proceeds from issuance of common stock under at-the-market program, net of issuance costs
21,006
Proceeds from issuance of common stock and pre-funded warrants in public offering, net of issuance costs
269,903
Net cash provided by financing activities
289,633
Net change in cash and cash equivalents
3,016
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock and...
$269,903K
Proceeds from issuance of
common stock under...
$21,006K
Proceeds from issuance of
common stock under...
$263K
Proceeds from issuance of
common stock upon...
$59K
Net cash provided by
financing activities
$289,633K
Canceled cashflow
$1,598K
Net change in cash
and cash...
$3,016K
Canceled cashflow
$286,617K
Payments for taxes
related to net share...
$1,598K
Stock-based compensation
$14,531K
Accrued expenses
$4,150K
Other noncurrent
liabilities
$877K
Amortization of debt discount
and accretion of...
$773K
Noncash operating lease
expense
$316K
Depreciation
$18K
Proceeds from sales and
maturities of marketable...
$212,131K
Net cash used in
operating activities
-$172,162K
Net cash used in
investing activities
-$114,455K
Canceled cashflow
$20,665K
Canceled cashflow
$212,131K
Net loss
-$182,779K
Purchases of marketable
securities
$326,514K
Net accretion of
discounts on investments...
$4,224K
Prepaid expenses and
other assets
$4,202K
Accounts payable
-$752K
Change in fair value of
warrant liability
-$516K
Operating lease
liabilities
-$354K
Purchases of property and
equipment
$72K
Buy us a coffee
89bio, Inc. (ETNB)
89bio, Inc. (ETNB)